AtriCure (NASDAQ:ATRC) Price Target Raised to $68.00

AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective lifted by equities research analysts at BTIG Research from $56.00 to $68.00 in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. BTIG Research’s price objective points to a potential upside of 17.79% from the stock’s current price. A number of other […]

Related Keywords

United States ,Maggie Yuen ,Karen Prange ,Stifel Nicolaus ,Bergankdv Wealth Management ,Needham Company ,Marks Group Wealth Management Inc ,Securities Exchange Commission ,Atricure Inc ,Northcrest Asset Manangement ,Dfpg Investments ,Get Free Report ,Director Karen Prange ,Exchange Commission ,Director Maggie Yuen ,Crest Asset Manangement ,Group Wealth Management Inc ,Isolator Synergy Clamps ,Atricure Daily ,Atricure ,Nasdaq Atrc ,Atrc ,Medical ,04963c20 ,Boost Price Target ,Btig Research ,